DaVita
DVA
#1877
Rank
A$16.24 B
Marketcap
A$253.02
Share price
0.50%
Change (1 day)
23.67%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): A$16.39

According to DaVita's latest financial reports the company's current EPS (TTM) is A$15.46. In 2025 the company made an earnings per share (EPS) of A$14.22 a decrease over its 2024 EPS that were of A$15.50.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$16.3915.29%
2025A$14.22-8.25%
2024A$15.5044.94%
2023A$10.6927.26%
2022A$8.40-35.56%
2021A$13.0444.1%
2020A$9.0519.7%
2019A$7.56540.48%
2018A$1.18-76.07%
2017A$4.93-19.31%
2016A$6.11242.52%
2015A$1.78-62.87%
2014A$4.8113.43%
2013A$4.248.45%
2012A$3.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$34.16 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.96 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$27.25 76.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.91-81.20%๐Ÿ‡บ๐Ÿ‡ธ USA